Comparison between Alkali Metals IPO and Chemcel Bio-tech IPO.
Alkali Metals IPO is a Mainboard Fixed Price IPO proposed to list at BSE, NSE while Chemcel Bio-tech IPO is a Mainboard Fixed Price proposed to list at BSE.
The total issue size of Alkali Metals IPO is up to ₹26.27 Cr whereas the issue size of the Chemcel Bio-tech IPO is up to ₹22.08 Cr. The final issue price of Alkali Metals IPO is ₹103.00 per share and of Chemcel Bio-tech IPO is ₹16.00 per share.
| Alkali Metals IPO | Chemcel Bio-tech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹86.00 per share | |
| Issue Price (Upper) | ₹103.00 per share | |
| Issue Price (Final) | ₹103.00 per share | ₹16.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 65 shares | |
| Fresh Issue Size | 25,50,000 shares | 1,38,00,206 shares |
| Fresh Issue Size (Amount) | up to ₹26.27 Cr | up to ₹22.08 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 25,50,000 shares | 1,38,00,206 shares |
| Issue Size Total (Amount) | up to ₹26.27 Cr | up to ₹22.08 Cr |
Alkali Metals IPO opens on Oct 07, 2008, while Chemcel Bio-tech IPO opens on Sep 09, 2008. The closing date of Alkali Metals IPO and Chemcel Bio-tech IPO is Oct 15, 2008, and Sep 12, 2008, respectively.
| Alkali Metals IPO | Chemcel Bio-tech IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Oct 07, 2008 | Sep 09, 2008 |
| Issue Close | Oct 15, 2008 | Sep 12, 2008 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Nov 06, 2008 | Oct 13, 2008 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Alkali Metals IPO P/E ratio is , as compared to Chemcel Bio-tech IPO P/E ratio of .
| Alkali Metals IPO | Chemcel Bio-tech IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 99.99 | 57.23 | ||||
| Promoter Shareholding (Post-Issue) | 74.95 | 29.4 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹104.88 Cr. | ₹41.47 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 23.27 | 9.14 |
In the Alkali Metals IPO Retail Individual Investors (RII) are offered 8,92,500 shares while in Chemcel Bio-tech IPO retail investors are offered 8,92,500 shares. Qualified Institutional Buyers (QIB) are offered 12,75,000 shares in Alkali Metals IPO and in Chemcel Bio-tech IPO.
| Alkali Metals IPO | Chemcel Bio-tech IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 12,75,000 shares | |
| NII | 3,82,500 shares | 64,00,000 shares |
| RII | 8,92,500 shares | 64,00,000 shares |
| Employee | 10,00,000 shares | |
| Others | ||
| Total | 25,50,000 shares | 1,38,00,000 shares |
Alkali Metals IPO subscribed 1.04x in total, whereas Chemcel Bio-tech IPO subscribed 1.70x.
| Alkali Metals IPO | Chemcel Bio-tech IPO | |
|---|---|---|
| QIB (times) | 0.72x | |
| NII (times) | 3.09x | 1.06x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.63x | 2.59x |
| Employee (times) | 0.03x | |
| Other (times) | ||
| Total (times) | 1.04x | 1.70x |
